Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Efficacy Standard Is Target Of WLF Suit; “Tiered” Approvals Proposed

Executive Summary

FDA should grant "initial" approvals based on evidence of efficacy derived from case histories, the Washington Legal Foundation asserts in a lawsuit seeking creation of a tiered drug approval system

You may also be interested in...



FDA Regs On Experimental Drug Access May Be Loosened After Court Loss

FDA's ongoing development of rules for expanded access programs will likely take a broader approach after the agency's current standards were questioned by an appeals court

FDA Regs On Experimental Drug Access May Be Loosened After Court Loss

FDA's ongoing development of rules for expanded access programs will likely take a broader approach after the agency's current standards were questioned by an appeals court

FDA Defends Efficacy Standard In Response To WLF Suit

There is no constitutional right of access to experimental medicines, FDA declares in a court brief opposing the Abigail Alliance's proposal for a "tiered" drug approval process

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

PS042232

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel